医療法人永紘会 足立内科クリニック
Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.
The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →
Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive
02E2601003 +1Location
- Prefecture
- Osaka
- Address
- 大阪市旭区清水三丁目1番14号 柴眼科ビル3階
Plan classification
- Class INot registered
- Class IINot registered
- Class IIIThe low-risk category under the law.
Certified committee for regenerative medicine
- 日本薬事法務学会再生医療等委員会
Public score
26.2/ 100
- A · Review level
- 10.0 / 30
- B · Technologies
- 12.6 / 35
- C · Coverage
- 3.6 / 25
- D · Class I / II technologies
- 0.0 / 10
The public score is calculated from public registration information and does not reflect quality of care. Scoring method →
Registered technologies (2)
NK and immune cells 2
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 成分採血での悪性腫瘍の抑制及び治療のためのGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®) | NK and immune cells | Class III |
| 全血採血での悪性腫瘍の抑制及び治療のためのGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®Ⅱ) | NK and immune cells | Class III |
Certified committee for regenerative medicine
- 日本薬事法務学会再生医療等委員会
Public document number
02E260100302E2601004
Plan classification · Certified committee for regenerative medicine · Public document number
| Registered technologies | Plan classification | Certified committee for regenerative medicine | Public document number |
|---|---|---|---|
| 成分採血での悪性腫瘍の抑制及び治療のためのGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®) | Class III | 日本薬事法務学会再生医療等委員会 | 02E2601003 |
| 全血採血での悪性腫瘍の抑制及び治療のためのGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT®Ⅱ) | Class III | 日本薬事法務学会再生医療等委員会 | 02E2601004 |
Other institutions in the same prefecture
- 旭泌尿器クリニックPublic score 26.2
- 医療法人健浩会中西クリニックPublic score 26.2
- 医療法人仁善会 田中クリニックPublic score 26.2
- 医療法人博慈会 中川クリニックPublic score 26.2
- 医療法人眞愛会 伊東くりにっくPublic score 26.2
- 一般社団法人澄佳会 松山淳記念クリニックPublic score 26.2
- 松下診療所Public score 26.2
- 大阪トリニティクリニックPublic score 26.2